| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 1,921,000 | 2,177,000 | 2,272,000 | 2,339,000 | | Cost of Revenue | 998,000 | 1,165,000 | 1,229,000 | 1,305,000 | | | Gross Profit | 923,000 | 1,012,000 | 1,043,000 | 1,034,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 365,000 | 352,000 | 375,000 | 391,000 | | Non Recurring | 453,000 | 144,000 | 264,000 |
-
| | Others | 8,000 | 6,000 | 5,000 | 6,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 97,000 | 510,000 | 399,000 | 637,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (14,000) | (25,000) | 3,000 | 11,000 | | Earnings Before Interest And Taxes | 83,000 | 485,000 | 402,000 | 648,000 | | Interest Expense | 66,000 | 67,000 | 68,000 | 68,000 | | Income Before Tax | 17,000 | 418,000 | 334,000 | 580,000 | | Income Tax Expense | 9,000 | 160,000 | 123,000 | 216,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 8,000 | 258,000 | 211,000 | 364,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 8,000 | 258,000 | 211,000 | 364,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $8,000 | $258,000 | $211,000 | $364,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
